Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial
- 1 August 2005
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 366 (9487), 717-725
- https://doi.org/10.1016/s0140-6736(05)67176-0
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malariaBritish Journal of Clinical Pharmacology, 2003
- Randomized Comparison of Artesunate and Quinine in the Treatment of Severe Falciparum MalariaClinical Infectious Diseases, 2003
- Central Role of the Spleen in Malaria Parasite ClearanceThe Journal of Infectious Diseases, 2002
- A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1997
- The disposition of intramuscular artemether in children with cerebral malaria; a preliminary studyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1997
- Role of quinine in the high mortality of intramuscular injection tetanusThe Lancet, 1994
- Quinine in severe falciparum malaria: evidence of declining efficacy in ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- Fatal Plasmodium falciparum Malaria after an Inadequate Response to Quinine TreatmentThe Journal of Infectious Diseases, 1990
- Severe Hypoglycemia and Hyperinsulinemia in Falciparum MalariaThe New England Journal of Medicine, 1983